These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 18157856)
21. Syntheses and biological activities of disaccharide daunorubicins. Zhang G; Fang L; Zhu L; Aimiuwu JE; Shen J; Cheng H; Muller MT; Lee GE; Sun D; Wang PG J Med Chem; 2005 Aug; 48(16):5269-78. PubMed ID: 16078845 [TBL] [Abstract][Full Text] [Related]
22. Design, synthesis, and biological evaluation of indenoisoquinoline topoisomerase I inhibitors featuring polyamine side chains on the lactam nitrogen. Nagarajan M; Xiao X; Antony S; Kohlhagen G; Pommier Y; Cushman M J Med Chem; 2003 Dec; 46(26):5712-24. PubMed ID: 14667224 [TBL] [Abstract][Full Text] [Related]
23. Intercalation into DNA is not required for inhibition of topoisomerase I by indolocarbazole antitumor agents. Bailly C; Dassonneville L; Colson P; Houssier C; Fukasawa K; Nishimura S; Yoshinari T Cancer Res; 1999 Jun; 59(12):2853-60. PubMed ID: 10383146 [TBL] [Abstract][Full Text] [Related]
24. Synthesis and biological evaluation of novel naphthocarbazoles as potential anticancer agents. Routier S; Peixoto P; Mérour JY; Coudert G; Dias N; Bailly C; Pierré A; Léonce S; Caignard DH J Med Chem; 2005 Mar; 48(5):1401-13. PubMed ID: 15743184 [TBL] [Abstract][Full Text] [Related]
25. Functionalized and [a]-anellated carbazoles as potential B-DNA ligands: experimental studies of DNA binding and molecular modeling of intercalation complexes. Pindur U; Marotto A; Schulze E; Fischer G Pharmazie; 2000 Oct; 55(10):727-32. PubMed ID: 11082831 [TBL] [Abstract][Full Text] [Related]
26. Synthesis and identification of novel indolo[2,3-a]pyrimido[5,4-c]carbazoles as a new class of anti-cancer agents. Pierce LT; Cahill MM; Winfield HJ; McCarthy FO Eur J Med Chem; 2012 Oct; 56():292-300. PubMed ID: 22910137 [TBL] [Abstract][Full Text] [Related]
27. DNA binding and topoisomerase I poisoning activities of novel disaccharide indolocarbazoles. Facompre M; Carrasco C; Colson P; Houssier C; Chisholm JD; Van Vranken DL; Bailly C Mol Pharmacol; 2002 Nov; 62(5):1215-27. PubMed ID: 12391286 [TBL] [Abstract][Full Text] [Related]
28. 2,4,6-Trisubstituted pyridines: Synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship. Basnet A; Thapa P; Karki R; Na Y; Jahng Y; Jeong BS; Jeong TC; Lee CS; Lee ES Bioorg Med Chem; 2007 Jul; 15(13):4351-9. PubMed ID: 17493824 [TBL] [Abstract][Full Text] [Related]
29. Design and synthesis of N-methylmaleimide indolocarbazole bearing modified 2-acetamino acid moieties as Topoisomerase I inhibitors. Li Z; Zhai F; Zhao L; Guo Q; You Q Bioorg Med Chem Lett; 2009 Jan; 19(2):406-9. PubMed ID: 19058964 [TBL] [Abstract][Full Text] [Related]
30. Synthesis and antitumor effect in vitro and in vivo of substituted 1,3-dihydroindole-2-ones. Christensen MK; Erichsen KD; Trojel-Hansen C; Tjørnelund J; Nielsen SJ; Frydenvang K; Johansen TN; Nielsen B; Sehested M; Jensen PB; Ikaunieks M; Zaichenko A; Loza E; Kalvinsh I; Björkling F J Med Chem; 2010 Oct; 53(19):7140-5. PubMed ID: 20845961 [TBL] [Abstract][Full Text] [Related]
31. Antitumor efficacy of edotecarin as a single agent and in combination with chemotherapy agents in a xenograft model. Ciomei M; Croci V; Ciavolella A; Ballinari D; Pesenti E Clin Cancer Res; 2006 May; 12(9):2856-61. PubMed ID: 16675581 [TBL] [Abstract][Full Text] [Related]
32. Semi-synthesis, topoisomerase I and kinases inhibitory properties, and antiproliferative activities of new rebeccamycin derivatives. Moreau P; Gaillard N; Marminon C; Anizon F; Dias N; Baldeyrou B; Bailly C; Pierré A; Hickman J; Pfeiffer B; Renard P; Prudhomme M Bioorg Med Chem; 2003 Nov; 11(23):4871-9. PubMed ID: 14604648 [TBL] [Abstract][Full Text] [Related]
33. Analogues of antifungal tjipanazoles from rebeccamycin. Voldoire A; Moreau P; Sancelme M; Matulova M; Léonce S; Pierré A; Hickman J; Pfeiffer B; Renard P; Dias N; Bailly C; Prudhomme M Bioorg Med Chem; 2004 Apr; 12(8):1955-62. PubMed ID: 15051063 [TBL] [Abstract][Full Text] [Related]
34. DNA binding ellipticine analogues: synthesis, biological evaluation, and structure-activity relationships. Ferlin MG; Marzano C; Gandin V; Dall'Acqua S; Dalla Via L ChemMedChem; 2009 Mar; 4(3):363-77. PubMed ID: 19197924 [TBL] [Abstract][Full Text] [Related]
35. Synthesis and mechanism of action studies of a series of norindenoisoquinoline topoisomerase I poisons reveal an inhibitor with a flipped orientation in the ternary DNA-enzyme-inhibitor complex as determined by X-ray crystallographic analysis. Ioanoviciu A; Antony S; Pommier Y; Staker BL; Stewart L; Cushman M J Med Chem; 2005 Jul; 48(15):4803-14. PubMed ID: 16033260 [TBL] [Abstract][Full Text] [Related]
36. Synthesis and biological evaluation of distamycin analogues - new potential anticancer agents. Drozdowska D; Rusak M; Miltyk W; Midura-Nowaczek K Arch Pharm (Weinheim); 2009 Feb; 342(2):87-93. PubMed ID: 19173336 [TBL] [Abstract][Full Text] [Related]
37. A novel class of in vivo active anticancer agents: achiral seco-amino- and seco-hydroxycyclopropylbenz[e]indolone (seco-CBI) analogues of the duocarmycins and CC-1065. Sato A; McNulty L; Cox K; Kim S; Scott A; Daniell K; Summerville K; Price C; Hudson S; Kiakos K; Hartley JA; Asao T; Lee M J Med Chem; 2005 Jun; 48(11):3903-18. PubMed ID: 15916443 [TBL] [Abstract][Full Text] [Related]
39. Rebeccamycin analogues bearing amine substituents or other groups on the sugar moiety. Anizon F; Moreau P; Sancelme M; Laine W; Bailly C; Prudhomme M Bioorg Med Chem; 2003 Aug; 11(17):3709-22. PubMed ID: 12901916 [TBL] [Abstract][Full Text] [Related]
40. Aromatic analogues of DNA minor groove binders--synthesis and biological evaluation. Pućkowska A; Bielawski K; Bielawska A; Midura-Nowaczek K Eur J Med Chem; 2004 Jan; 39(1):99-105. PubMed ID: 14987838 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]